Quetiapine successfully treating oculogyric crisis induced by antipsychotic drugs

Journal of Clinical Neuroscience

Volumn 14, Issue 4, 2007, Pages 396-398

  Gourzis, Philippos ^a   Polychronopoulos, Panagiotis ^a   Argyriou, Andreas A ^a   Chroni, Elisabeth ^a   Beratis, Stavroula ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Antipsychotics; Extrapyramidal side effects; Oculogyric crisis; Quetiapine; Tardive dystonia

Indexed keywords

BIPERIDEN; CERULOPLASMIN; CYANOCOBALAMIN; HALOPERIDOL; OLANZAPINE; QUETIAPINE; RISPERIDONE; SERTINDOLE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; MALE; MONOTHERAPY; OCULOGYRIC CRISIS; PARANOID SCHIZOPHRENIA; PRIORITY JOURNAL;

ADULT; ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; HUMANS; MALE; OCULAR MOTILITY DISORDERS; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 33847307491     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2006.04.006     Document Type: Article

References (13)

1. FitzGerald P.M., and Jaknovic J. Tardive oculogyric crises. Neurology 39 (1989) 1434-1437
2. Nasrallah H.A., Pappas N.J., and Crowe R.R. Oculogyric dystonia in tardive dyskinesia. Am J Psychiatry 137 (1980) 850-851
3. Kay S.R., Fiszbein A., and Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13 (1987) 261-276
4. Gourzis P., Polychronopoulos P., Papapetropoulos S., et al. Quetiapine in the treatment of focal tardive dystonia induced by other atypical antipsychotics: a report of 2 cases. Clin Neuropharmacol 28 (2005) 195-196
5. Adityanjee, and Estera A. Successful treatment of tardive dystonia with clozapine. Biol Psychiatry 39 (1996) 1064-1065
6. 2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine: relation to extrapyramidal side effects. Arch Gen Psychiatry 49 (1992) 538-544
7. Saller C.F., and Salama A.I. Seroquel: biochemical profile of a potential atypical antipsychotic. Psychopharmacology (Berl) 112 (1993) 285-292
8. Kasper S., Tauscher J., and Heiden A. Quetiapine: efficacy and tolerability in schizophrenia. Eur Neuropsychopharmacol 11 Suppl.4 (2001) S405-S413
9. 2 receptor occupancy of clozapine, risperidone and olanzapine in schizophrenia. Am J Psychiatry 156 (1999) 286-293
10. 2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine. Am J Psychiatry 156 (1999) 876-884
11. 2 receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient. Biolog Psychiatry 50 (2001) 873-883
12. Kapur S., and Seeman P. Does fast dissociation from the dopamine D2 receptors explain the action of atypical antipsychotics? A new hypothesis. Am J Psychiatry 158 (2001) 360-369
13. Nasrallah H.A., and Mulvihill T. Iatrogenic disorders associated with conventional vs atypical antipsychotics. Ann Clin Psychiatry 13 (2001) 215-227